Which antidepressants have demonstrated superior efficacy? A review of the evidence
Stuart Montgomery(University of London), Michael E. Thase(Veterans Health Administration), David Nutt(Imperial College London), Siegfried Kasper(Medical University of Vienna), Naomi Fineberg(University of Hertfordshire), Alan F. Schatzberg(Stanford University), Pierre Blier(Université du Québec à Rimouski), Raymond W. Lam(Hong Kong Adventist Hospital), Hans‐Jürgen Möller(Medical University of Vienna), David S. Baldwin(University of Southampton), Malcolm Lader(King's College - North Carolina), Jean‐Pierre Lépine, Frédéric Rouillon(Centre Hospitalier Sainte-Anne)
Cited by 164
Related Papers
The 16-Item quick inventory of depressive symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression
|Biological Psychiatry|2003|3.9k
Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care
|World Psychiatry|2011|2.5k
Resting-state connectivity biomarkers define neurophysiological subtypes of depression
|Nature Medicine|2016|2.2k
Major depressive disorder
|Nature Reviews Disease Primers|2016|2.1k